AVBT — Avisa Diagnostics Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Avisa Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.194 | 0.839 | 0.278 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.101 | 0.432 | 0.129 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.09 | 0.025 | 4.01 | 4.97 | 0.994 |
| Operating Profit | -0.09 | -0.025 | -3.82 | -4.14 | -0.716 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.089 | -0.043 | -6.5 | -4.13 | -0.716 |
| Net Income After Taxes | -0.089 | -0.043 | -6.5 | -4.13 | -0.716 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.089 | -0.043 | -6.5 | -4.13 | -0.716 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.089 | -0.043 | -6.5 | -4.13 | -0.716 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.762 | -0.203 | -1.44 | -0.542 | -0.148 |